
Theodore E Okerson II MD FACE, FACP, FTOS
Endocrinology, Cardiology, Obesity Medicine & Nutrition, Nephrology
Senior Field Physician; Senior Medical Director: Cardiovascular/Renal/Metabolic Disease AstraZeneca
Join to view full profile
951 N. World Cup LaneEagle, ID 83616
Phone+1 208-917-3142
Dr. Okerson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Theodore Okerson II is an internal medicine specialist based in Eagle, ID, with subspecialties in endocrinology, cardiology, obesity medicine and nutrition, and nephrology. He completed his residency in internal medicine at the University of California, Irvine, following his graduation from Oral Roberts University School of Medicine in 1983. He holds a B.A. & B.S. in chemistry and biology from Chapman College, and a Masters in Advanced Studies in clinical research from the University of California San Diego. He served as an Assistant Clinical Professor at UC Irvine's School of Medicine from 2001 to 2019 and has experience in heart failure, chronic kidney disease, cardiology, hyperlipidemia, and wellness. Dr. Okerson has multiple publications related to diabetes, obesity and lipid-lowering therapy and statin treatment patterns. He has received several awards, including the Spirit of US Award from Amgen and the Physician of Excellence award from the Orange County Medical Association.
Education & Training
University of California, San DiegoMAS, Clinical Research, 2002 - 2006
University of California, San DiegoM.A.S., Clinical Research, 2002 - 2005
University of California (Irvine)Residency, Internal Medicine, 1983 - 1987
Oral Roberts University School of MedicineClass of 1983
Chapman CollegeB.A. & B.S., Chemistry; & Biology, Magna Cum Laude, 1974 - 1978
Certifications & Licensure
ID State Medical License 2023 - 2028
CA State Medical License 1984 - 2027
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Spirit of US Award Amgen, 2015, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2015
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014-2015
Publications & Presentations
PubMed
- 11 citationsControl of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) studySteven V. Edelman, Daisy S. Ng-Mak, Mark A Fusco, David Ashton, Ted Okerson
Diabetes, Obesity & Metabolism. 2014-10-01 - 5 citationsWeight loss through adjustable gastric banding and improvement in daytime sleepiness: 2 year interim results of APEX study.Mark A Fusco, Steven James, Christopher T. Cornell, Ted Okerson
Current Medical Research and Opinion. 2014-01-17 - 3 citationsInterim results at 48 weeks of LAP-BAND AP experience (APEX) study: prospective, multicenter, open-label longitudinal patient observational studyRobert Cywes, Sunil Bhoyrul, Helmuth Billy, Jaime Ponce, Ted Okerson
Surgery for Obesity and Related Diseases. 2012-11-01
Journal Articles
- "Effects of Exenatide on Systolic Blood Pressure in Subjects with Type 2 Diabetes"Okerson T, Yan P, Stonehouse A, Brodows R, American Journal of Hypertension, 1/1/2010
- "Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Pat...Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ, J Am Heart Assoc, 1/1/2017
- "Quality of Life after Laparoscopic Adjustable Gastric Banding (LAP-BAND): APEX Interim 3-Year Analysis"Billy HT, Sarwer DB, Ponce J, Ng-Mak D, Shi R, Cornell C, Okerson T, Postgraduate Medicine, 1/1/2014
Abstracts/Posters
- "Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Cardiovascular Disease"Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston MS, Okerson T, American Diabetes Association 77th Scientific Sessions, San Diego, CA, 1/1/2017
- "Lipid-lowering Therapy Prescription Patterns and Predictors of High Intensity Statin Prescriptions in Patients With Diabetes or Atherosclerotic Cardiovascular Disease."Chamberlain AM, Cohen SS, Killian JM, Monda KL, Hedgeman EO, Weston SA, Okerson T, Circulation, Epi/Lifestyle 2017 Scientific Sessions, Portland, OR, 1/1/2017
- "Changes in Lipid-Lowering Therapy Following a Cardiovascular Event in Patients with Diabetes Mellitus"Okerson T, Cohen S, Killian J, Weston S, Monda K, Chamberlain A, 53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon, Portugal, 1/1/2017
Lectures
- "Early Intervention with Bariatric Surgery in Type 2 Diabetes"Saalfelden, Austria - 1/11/2012
- "GLP-1 and Bariatric Surgery: Updates, Synergies and Potential CV Benefits"Saalfelden, Austria - 1/11/2012
- "Effect of Early Weight Loss on Type 2 Diabetes through Surgical Intervention 2 Years after Gastric Banding"Philadelphia, PA - 1/1/2012
Professional Memberships
- Fellow
- Fellow
- The Obesity SocietyFellow
External Links
- LinkedInhttps://www.linkedin.com/in/tedokersonmd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









